JAAD Game Changers: "Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate". Grant-Kels JM. J Am Acad Dermatol 2024 Jun 13:S0190-9622(24)00901.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Grant-Kels JM. JAAD Game Changers: "Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate". J Am Acad Dermatol 2024 Jun 13:S0190-9622(24)00901.
PMID: 38879127